Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Resonant Mixing in Glass Bowl Microbioreactor Investigated by Microparticle Image Velocimetry.

Meinen S, Frey LJ, Krull R, Dietzel A.

Micromachines (Basel). 2019 Apr 27;10(5). pii: E284. doi: 10.3390/mi10050284.

2.

Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice.

Reinhard JR, Lin S, McKee KK, Meinen S, Crosson SC, Sury M, Hobbs S, Maier G, Yurchenco PD, Rüegg MA.

Sci Transl Med. 2017 Jun 28;9(396). pii: eaal4649. doi: 10.1126/scitranslmed.aal4649.

3.

Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy.

Willmann R, Gordish-Dressman H, Meinen S, Rüegg MA, Yu Q, Nagaraju K, Kumar A, Girgenrath M, Coffey CBM, Cruz V, Van Ry PM, Bogdanik L, Lutz C, Rutkowski A, Burkin DJ.

J Neuromuscul Dis. 2017;4(2):115-126. doi: 10.3233/JND-170217. Review.

4.

Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype.

McKee KK, Crosson SC, Meinen S, Reinhard JR, Rüegg MA, Yurchenco PD.

J Clin Invest. 2017 Mar 1;127(3):1075-1089. doi: 10.1172/JCI90854. Epub 2017 Feb 20.

5.

Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.

Meinen S, Lin S, Rüegg MA, Punga AR.

PLoS One. 2012;7(8):e44148. doi: 10.1371/journal.pone.0044148. Epub 2012 Aug 28.

6.
7.

Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice.

Meinen S, Lin S, Thurnherr R, Erb M, Meier T, Rüegg MA.

EMBO Mol Med. 2011 Aug;3(8):465-79. doi: 10.1002/emmm.201100151. Epub 2011 Jun 15.

8.

Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.

Punga AR, Lin S, Oliveri F, Meinen S, Rüegg MA.

Exp Neurol. 2011 Aug;230(2):207-17. doi: 10.1016/j.expneurol.2011.04.018. Epub 2011 Apr 30.

PMID:
21565192
9.

MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.

Punga AR, Maj M, Lin S, Meinen S, Rüegg MA.

Eur J Neurosci. 2011 Mar;33(5):890-8. doi: 10.1111/j.1460-9568.2010.07569.x. Epub 2011 Jan 24.

PMID:
21255125
10.

Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency.

Erb M, Meinen S, Barzaghi P, Sumanovski LT, Courdier-Früh I, Rüegg MA, Meier T.

J Pharmacol Exp Ther. 2009 Dec;331(3):787-95. doi: 10.1124/jpet.109.160754. Epub 2009 Sep 16.

PMID:
19759319
11.

Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.

Meinen S, Barzaghi P, Lin S, Lochmüller H, Ruegg MA.

J Cell Biol. 2007 Mar 26;176(7):979-93.

12.

Congenital muscular dystrophy: mini-agrin delivers in mice.

Meinen S, Ruegg MA.

Gene Ther. 2006 Jun;13(11):869-70. No abstract available.

PMID:
17262906

Supplemental Content

Loading ...
Support Center